Showing results (131-140 of 170) with videos related to

Sort By:
Pageof 17
Archiv Der Pharmazie|January 10, 2024
Triazole derivatives as potential xanthine oxidase inhibitors: Design, enzyme inhibition potential, and docking studiesHarmandeep Kaur Gulati, Aanchal Khanna, Nitish Kumar, et al.
Natural Product Research|October 10, 2022
Shikonin derivatives as potent xanthine oxidase inhibitors: in-vitro studyNitish Kumar, Ankita Rajput, Harmandeep Kaur, et al.
Journal of Clinical Anesthesia|November 28, 2024
Comparative efficacy of intravenous treatments for perioperative shivering in patients undergoing caesarean delivery under neuraxial anaesthesia: A systematic review and Bayesian network meta-analysis of randomised-controlled trialsGuillermina Ferrea, David T Monks, Preet Mohinder Singh, et al.
Journal of Pineal Research|April 7, 2026
Melatonin Receptor-Mediated Signaling and PGPR-Induced Secondary Metabolic Defense Dome Confer Cadmium Tolerance in Brassica juncea: Transcriptomic and Docking InsightsTamanna Bhardwaj, Renu Bhardwaj, Nancy Sharma, et al.
Molecular Diversity|January 22, 2024
Antidiabetic potential of thiazolidinedione derivatives with efficient design, molecular docking, structural activity relationship, and biological activity: an update review (2021-2023)Anchal Sharma, Nitish Kumar, Harmandeep Kaur Gulati, et al.
World Neurosurgery|August 2, 2021
Effects of Various Therapeutic Agents on Vasospasm and Functional Outcome After Aneurysmal Subarachnoid Hemorrhage-Results of a Network Meta-AnalysisSandeep Mishra, Kanwaljeet Garg, Vishwa Bharathi Gaonkar, et al.
Chemical Biology & Drug Design|June 28, 2022
Synthetic heterocyclic derivatives as promising xanthine oxidase inhibitors: An overviewGurinder Kaur, Atamjit Singh, Geetakshi Arora, et al.
Expert Opinion on Therapeutic Patents|October 3, 2022
Dihydrofolate reductase inhibitors: patent landscape and phases of clinical development (2001-2021)Kavita Bhagat, Nitish Kumar, Harmandeep Kaur Gulati, et al.
ACS Chemical Neuroscience|September 8, 2023
Pathogenesis of Alzheimer's Disease and Diversity of 1,2,3-Triazole Scaffold in Drug Development: Design Strategies, Structural Insights, and Therapeutic PotentialAtamjit Singh, Karanvir Singh, Jashandeep Kaur, et al.
Molecular Diversity|August 20, 2024
A comprehensive review of synthetic and semisynthetic xanthine oxidase inhibitors: identification of potential leads based on in-silico computed ADME characteristicsRupali Rana, Anchal Sharma, Nitish Kumar, et al.
Pageof 17